AngioDynamics, Inc. (ANGO)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, AngioDynamics, Inc. currently loses $13.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 1
in 21 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
AngioDynamics topped consensus on both the top and bottom line in the fourth fiscal quarter of 2026, reported July 14, 2026, with revenue up 8.0% to about $86.6 million. Adjusted EPS of -$0.07 topped the -$0.11 estimate by $0.04, while revenue of $86.6 million topped the $80.2 million estimate (+7.9%). On profitability, gross margin was 57.1% and operating margin was -23.5%, as the company posted an operating loss of roughly $20.4 million on gross profit of about $49.4 million. Net income was a loss of around $11.4 million, down 88.5% year over year from a loss of about $6.0 million, and adjusted EPS of -$0.07 compared with -$0.03 a year ago. Cash generation was positive, with operating cash flow of roughly $17.5 million. For the next period, consensus calls for EPS of -$0.11 on revenue of $80.5 million.
Next report — what to expect
AngioDynamics, Inc. (ANGO) reports earnings on October 1, 2026. Wall Street is looking for consensus EPS of -$0.112 on revenue of $80.5 million. For trailing context, revenue grew +8.0% year over year last quarter. ANGO has beaten EPS in 7 of 8 most recent quarters, so results versus consensus will be in focus.
About AngioDynamics, Inc.
AngioDynamics, Inc. designs, makes, and sells medical devices used in cancer treatment, vascular access, and image-guided procedures. Listed on NASDAQ as ANGO, the company operates in healthcare as a maker of medical instruments and supplies and generated $320.2 million of revenue in FY2026.
Today's Snapshot
ANGO closed 0.7% higher at 15.32.
Trading Volume
Below 10d avg (337.3K)
328.7K
vs S&P 500 Today
Outperforming Market
+1.14%
Updated: September 10, 2026 at 12:23 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$12.81 - $15.52Buy
- RSI (14)49.49Neutral
- Stochastic %K (14, 3, 3)27.55Neutral
- MACD Level (12, 26)0.17Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.